Tags

, , , , , , , , , , , , , , , , , , , ,

Rishi Sunak is being presented as the front runner for replacing Boris Johnson as British Prime Minister. However, in a head to head contest Sunak would be beaten by most other PM contenders: He would be trounced by Mordaunt, Truss, Badenoch, and Tugendhat, according to a new poll. https://twitter.com/PennyMordaunt/status/1547200107636051973

As of late 2020, Rishi Sunak’s wife, Akshata Murty, owns a 0.91% stake in Infosys, which is worth £430 million. Her father, NR Narayana Murthy, founded the company and is Chairman Emeritus. “Each year, her shares entitle her to millions in dividends. Of all the family, only her brother, Rohan Murty, owns more of the company. The combined family holding is worth an estimated £1.7bn…. Infosys is a contractor to the UK government and publicly funded organisations. Since 2015, the firm has won taxpayer-funded work worth £22m, according to filings on the government’s contracts website. These include a £5m deal with the Medicines and Healthcare products Regulatory Agency, awarded in 2018, which runs until 2021. Infosys has also worked for the Home Office and has signed a framework agreement with Whitehall, which means it can be awarded contracts without competition…“ https://www.theguardian.com/politics/2020/nov/27/huge-wealth-of-sunaks-family-not-declared-in-ministerial-register

Source of Wealth of UK PM Wannabe Rishi Sunak’s Family Not Declared in Ministerial Register; Infosys Founder-Chairman Emeritus (Rishi’s Father-in-Law) Even Flew from India to Campaign for Him

The modern computer was invented by an Englishman so why does an India based company have the contracts? “Charles Babbage, an English mechanical engineer and polymath, originated the concept of a programmable computer. Considered the “father of the computer”, he conceptualized and invented the first mechanical computer in the early 19th century.” https://en.wikipedia.org/wiki/Computer

On a related note, on July 13, 2022, it was announced: “Infosys to Acquire Life Sciences Consulting and Technology Leader, BASE life science: Acquisition to deepen life sciences domain capabilities and strengthen footprint across Europe“ https://web.archive.org/web/20220714055709/https://www.infosys.com/newsroom/press-releases/2022/acquire-life-sciences-consulting-technology.html

“Testing Services
Medicines and Healthcare Products Regulatory Agency (MHRA)
Published date: 16 June 2022
Awarded contract – This means that the contract has been awarded to a supplier.
Contract summary

Industry
* Information technology services – 72222300
Location of contract
E14 4PU
Value of contract
£350,000
Procurement reference
CF-0898900D0O000000rwimUAA1
Published date
16 June 2022
Closing date
1 May 2022
Closing time
12pm
Contract start date
2 May 2022
Contract end date
1 May 2023
Contract type
Service contract
Procedure type
Call-off from a framework agreement
What is a call-off from a framework agreement?
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No

Description

Testing Services

Award information
Awarded date
2 May 2022
Contract start date
2 May 2022
Contract end date
1 May 2023
Total value of contract
£350,000
This contract was awarded to 1 supplier.
Infosys Ltd
Show supplier information

About the buyer

Contact name
N/A
Address
South Collumnade
London
E14 4PU
GB
Email
MHRAcommercialcorrespondance@mhra.gov.uk”
This and additional contracts are found here: https://www.contractsfinder.service.gov.uk/notice/b98583b5-3ceb-4717-9399-9278dcc982d3?origin=SearchResults&p=1

About Medicines and Healthcare products Regulatory Agency:
“Medicines and Healthcare products Regulatory Agency
Services and information
Blood regulation and safety
Medical devices: how to comply with the legal requirements in Great Britain
MHRA fees
Make a payment to MHRA
Blood: authorisations and safety reporting
See more
Clinical trials and investigations
Oral COVID-19 antiviral, Paxlovid, approved by UK regulator
Clinical trials for medicines: apply for authorisation in the UK
Clinical trials for medicines: manage your authorisation, report safety issues
Notify the MHRA about a clinical investigation for a medical device
See more
Conferences and events
Conferences and events
Request a MHRA speaker at an event or conference
Good practice, inspections and enforcement
Good manufacturing practice and good distribution practice
Good clinical practice for clinical trials
MHRA phase I accreditation scheme
MHRA fees
See more
Herbal and homeopathic medicines
MHRA fees
Apply for a traditional herbal registration (THR)
List of banned or restricted herbal ingredients for medicinal use
Make a payment to MHRA
See more
Licensing
Medicines: reclassify your product
Manufacturing, wholesaling, importing and exporting medicines
Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients
Good manufacturing practice and good distribution practice
Medicines that you cannot export from the UK or hoard
Apply for manufacturer or wholesaler of medicines licences
See more
Marketing authorisations, variations and licensing guidance
First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA
Medicines: packaging, labelling and patient information leaflets
Innovative Licensing and Access Pathway
Apply for a licence to market a medicine in the UK
See more
Medical devices regulation and safety
Alerts, recalls and safety information: drugs and medical devices
Regulating medical devices in the UK
Consultation on the future regulation of medical devices in the United Kingdom
Register medical devices to place on the market
See more
Scientific research and development
Innovative Licensing and Access Pathway (ILAP): New partner announcement
Prime Minister kicks off major new science initiative at visit of MHRA’s National Institute for Biological Standards and Control
Vigilance, safety alerts and guidance
Alerts, recalls and safety information: drugs and medical devices
Drug Safety Update
Coronavirus (COVID-19) vaccines adverse reactions
Oral COVID-19 antiviral, Paxlovid, approved by UK regulator”
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency/services-information

Rishi Sunak’s Infosys Heiress Wife Claims Non-Dom Status to Avoid UK Taxes; Infosys Still in Russia Four Months After Invasion of Ukraine Despite Promises to Leave in April

When Meeting with Putin at Infosys, Rishi Sunak’s Father-in-law Spoke of India & Russia’s “Special Relationship” and “Common Values”

Rishi Sunak Helped Trigger Chain of Events Leading to 2008 Crisis; Apparently Used Corporate Raider Strategy Against UK PM Johnson in Attempt to Make Himself PM

India’s InfoSys Paid Record Amount to Settle US Visa Fraud-Immigration Abuse Allegations; Son-in-Law of Founder Eyeing UK PM Post After Undermining Boris Johnson